Compare SLGL & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLGL | DAVA |
|---|---|---|
| Founded | 1997 | 2000 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.1M | 220.4M |
| IPO Year | 2016 | 2015 |
| Metric | SLGL | DAVA |
|---|---|---|
| Price | $70.00 | $3.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $110.00 | $13.50 |
| AVG Volume (30 Days) | 16.0K | ★ 298.3K |
| Earning Date | 05-22-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $223.84 | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $3.61 |
| 52 Week High | $97.97 | $16.66 |
| Indicator | SLGL | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 33.86 |
| Support Level | $67.47 | N/A |
| Resistance Level | $81.66 | $7.10 |
| Average True Range (ATR) | 5.47 | 0.17 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 37.98 | 25.00 |
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.